Mohamed Hammad

Mohamed Hammad

Company: City of Hope

Job title: Assistant research professor

Seminars:

Neural Stem Cells as an Allogeneic Stem Cell-Based Platform for Oncolytic Virotherapy 10:30 am

NSC-based virotherapy has shown promising results in preclinical studies, demonstrating improved tumor targeting, enhanced virus replication, and increased antitumor efficacy compared to traditional oncolytic viral therapy alone NSCs can potentially be combined with other therapeutic modalities, such as chemotherapy or immunotherapy, to create synergistic effects and improve overall treatment outcomesRead more

day: Pre-Conference Day

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.